South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
Osstem Implant, a Seoul, South Korea-headquartered dental equipment and supplies manufacturing company, may be delisted from the Kosdaq stock market soon. The company announced late last week that it would be discussing the delisting move at the upcoming extraordinary general meeting of the company, which was scheduled for June 28.
Osstem Implant is reportedly planning to start the delisting process once the resolution is approved at the general meeting that is expected to be attended by its largest shareholders - MBK Partners and Unison Capital Korea private equity funds firms.
According to The Korea Herald, the consortium formed by MBK Partners and Unison Capital Korea has purchased a 96.1% stake in Osstem Implant after a second tender offer. The consortium has now indicated it resolved to proceed with the process of delisting from the secondary bourse Kosdaq.
It was reported that when the largest shareholder of a Kosday-listed company submits an application for voluntary delisting, the Korea Exchange will call for a corporate review committee to determine if the share ratio and tender offer of the largest stakeholder meet the standards for investor protection. The committee will also have to evaluate if it serves the public interest.
It was explained that the largest shareholder would acquire the small shares of minority shareholders if the delisting proposal is given the "go ahead" signal. The minority shares in the dental equipment manufacturing company are only 3.9%.
"If the delisting is approved following the KRX's review of the application, the largest shareholder will purchase the stock from retail investors who wish to sell it for a certain period of time which is likely around six months," an official of the Osstem Implant stated.
Meanwhile, The Korea Times reported that shares of Osstem Implant closed at KRW188,800 per share late last week. This is up by 1.67% compared to the previous session.
Photo by: Osstem Implant Press Room
